Group | Before treatment | At the 1 month | At the 3 months | At the 18 months | Last follow-up |
---|
Group A | 5.61 ± 1.63 | 4.75 ± 1.82 | 3.05 ± 1.53 | 2.56 ± 1.44 | 2.06 ± 1.07 |
Group B | 5.23 ± 1.23 | 3.05 ± 1.37 | 2.86 ± 1.67 | 2.19 ± 1.34 | 1.81 ± 1.01 |
P value | 0.075a | 0.045b | 0.231c | 0.416d | 0.384e |
- a There was no significant difference in VAS score before treatment between the two groups (Repeated measure analysis, p > 0.05)
- b There was significant difference in VAS score at the 1 month of treatment between the two groups (Repeated measure analysis, p < 0.05)
- c There was no significant difference in VAS score at the 3 months of treatment between the two groups (Repeated measure analysis, p > 0.05)
- d There was no significant difference in VAS score at the 18 months of treatment between the two groups (Repeated measure analysis, p > 0.05)
- e There was no significant difference in VAS score at the last follow-up between the two groups (Repeated measure analysis, p > 0.05)